Malignant gastrointestinal stromal tumors of the small intestine: A review of 50 cases from a prospective database

Annals of Surgical Oncology

Volumn 8, Issue 1, 2001, Pages 50-59

  Crosby, J A ^a   Catton, C N ^a   Davis, A ^a   Couture, J ^a   O'Sullivan, B ^a   Kandel, R ^a   Swallow, C J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Gastrointestinal stromal tumors; GIST; Intestinal sarcoma; Small intestinal neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL MUCOSA; HIGH RISK PATIENT; HUMAN; MALE; MESENCHYMOMA; METASTASIS; SMALL INTESTINE TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY; CHEMOTHERAPY, ADJUVANT; DATABASES, FACTUAL; FEMALE; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SARCOMA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035122393     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.1.50     Document Type: Article

References (49)

1. Soft tissue sarcomas
2. Gastric stromal tumors: Reappraisal of histogenesis
3. Differentiation and risk assessment of gastrointestinal stromal tumors
4. Gastrointestinal stromal tumors
5. Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
6. Mesenchymal tumors of the gastrointestinal tract: A paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-kit in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases?
7. Embryonic form of smooth muscle myosin heavy chain (Smemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal
8. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors
9. Congenital gastrointestinal pacemaker cell tumor
10. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
11. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
12. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumors
13. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
14. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
15. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
16. Gastrointestinal sarcomas. Analysis of prognostic factors
17. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging
18. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas
19. Stromal neoplasms of the rectum and anal canal
20. Leiomyosarcoma. A 45-year review at Charity Hospital, New Orleans
21. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Dependence on anatomic site
22. Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn't know
23. Gut stromal tumors and their clinical behavior
24. An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors
25. Stromal tumors of the jejunum and ileum. A clinicopathologic study of 39 cases
26. Stromal tumors of the jejunum and ileum
27. Small intestinal stromal tumors: A clinicopathologic study of 31 tumors
28. An institutional review of sarcomas of the large and small intestine
29. Nonparametric estimation from incomplete observations
30. Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival
31. Smooth muscle tumors of the gastrointestinal tract: Analysis of prognostic factors
32. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years
33. Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count
34. Immunophenotype, proliferation DNA, ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariable clinicopathologic study
35. Primary gastrointestinal sarcomas: Analysis of prognostic variables
36. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors
37. Malignant GI stromal tumors (M-GIST): 52 cases from a prospective database
38. Gastrointestinal stromal sarcomas
39. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma)
40. Late recurrence (33 years) of a gastric epithelioid stromal tumor (leiomyoblastoma) with low malignant potential
41. Gastric leiomyoblastoma with metastases to the liver. A 36 year follow-up study
42. Salvage surgery for patients with recurrent gastrointestinal sarcoma. Prognostic factors to guide patient selection
43. Adjuvant therapy of softtissue sarcomas
44. Myosarcomas of the stomach: Natural history, prognostic factors and management
45. Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas
46. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas